Inventor · disambiguated record
Gary Patou
Also filed as: PATOU GARY
7 granted patents·6 pending applications·17 citations·filing 2011–2024
82Inventor score
Top patents by PatentIndex Score
13 records- 0192US10617642B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2020·9 cites·20 claims
- 0284US10729651B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Aug 4, 2020·2 cites·14 claims
- 0383US10675245B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Jun 9, 2020·2 cites·19 claims
- 0483US2025339499A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 0579US2024016899A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 0677US10123974B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted Nov 13, 2018·2 cites·14 claims
- 0777US9974744B2Sustained release formulation of a non-steroidal anti-inflammatory drugPACIRA PHARMACEUTICALS INC·Filed 2013·Granted May 22, 2018·2 cites·20 claims
- 0877US2023173034A1Oral octreotide for the treatment of diseaseAMRYT ENDO INC·Filed 2023·Application pending·0 cites
- 0977US2025000933A1Terlipressin compositions and their methods of useAMRYT ENDO INC·Filed 2024·Application pending·0 cites
- 1068US2022313773A1Terlipressin compositions and their methods of useAMRYT ENDO INC·Filed 2021·Application pending·0 cites
- 1162US2021187079A1Oral octreotide for the treatment of diseaseCHIASMA INC·Filed 2017·Application pending·0 cites
- 1261US10610486B2Sustained release formulation of a non-steroidal anti-inflammatory drugGARCIA LOUIE DANIEL·Filed 2011·Granted Apr 7, 2020·0 cites·19 claims
- 1358US10993984B2Terlipressin compositions and their methods of useCHIASMA INC·Filed 2017·Granted May 4, 2021·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →